Concepedia

Takahisa� Nakanishi

TN

Statistics

Publications

16

Citations

435

H-Index

12

Active since

2012

Affiliations

Kansai Medical University(Current)

Takahisa� Nakanishi is an author at Kansai Medical University specializing in medicine, pharmacotherapy, and chemotherapy.

Publications per year

2012–2022

16

Publications

16

IL-33 Promotes the Induction and Maintenance of Th2 Immune Responses by Enhancing the Function of OX40 Ligand

Naoko Murakami-Satsutani, Tomoki� Ito, Takahisa� Nakanishi et al. · Allergology International · 2014 · 124 citations · Full text

, , +17

Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?

Aya Nakaya, Shinya� Fujita, Atsushi� Satake et al. · Leukemia Research · 2016 · 49 citations

, , +16

Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent Era

Aya Nakaya, Shinya� Fujita, Atsushi� Satake et al. · Hematology Reports · 2017 · 36 citations · Full text

, , +15

Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming

Makoto Ogata, Tomoki� Ito, Keiko Shimamoto et al. · International Immunology · 2012 · 35 citations · Full text

, , +16

Platelet-derived RANK ligand enhances CCL17 secretion from dendritic cells mediated by thymic stromal lymphopoietin

Takahisa� Nakanishi, Muneo Inaba, Noriko Inagaki‐Katashiba et al. · Platelets · 2014 · 24 citations

, , +17

1–5 of 16